Orion Pharma Limited — Company profile

Bangladesh

Last price 28.3 BDT (At close: Oct 29, 2026) · Market cap 6.62B

Latest research: Orion Pharma financial analysis: power revenue down 88%, BDT 25.6bn debt and a qualified audit (Oct 2026) · Orion Pharma: power revenue fell 88% after the plant contracts expired, leaving a BDT 25.6bn debt load on a pharma business earning BDT 251m

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Technical report: trend, RSI, support and resistance, charts

Company profile

Orion Pharma Limited engages in the creation, discovery, development, manufacturing, and marketing of pharmaceutical products in Bangladesh. It produces products in various dosage forms, including tablets, capsules, syrups, suspensions, injections, and dry powder for syrup/ suspension in various therapeutic groups, such as anticancer, antibiotics, anti-diabetics, anxiolytics, diuretics, cardiovascular drugs, etc. The company also provides various vaccines and health-related consumer products, as well as generates and supplies electricity. The company was formerly known as Orion Laboratories Limited and changed its name to Orion Pharma Limited in October 2010. Orion Pharma Limited was incorporated in 1965 and is based in Dhaka, Bangladesh.

Details

Key executives

Contact